Healthcare Risk Repriced
Analysts are re‑evaluating healthcare and life‑insurance risk: firms like RBC kept ratings on major insurers while sector commentary noted U.S. insurers lost substantial market capitalisation in Q1. Regional differences emerged too, with Asian and European insurers outperforming U.S. peers in recent moves. (investing.com, insuranceasia.com)
Investors are repricing health-insurance risk after United States managed-care groups lost $226 billion in market value in the first quarter of 2026. (insuranceasia.com) GlobalData said the biggest split ran by region: Asian and European insurers gained ground while United States peers fell, with the pressure centered on healthcare and life-insurance risk. Insurance Asia published the data on April 8, 2026, and described the move as a structural reassessment rather than a one-day selloff. (insuranceasia.com, globaldata.com) One reason is simple: insurers collect fixed premiums and pay variable medical bills, so higher use of care squeezes margins. UnitedHealth said its full-year 2025 adjusted medical care ratio rose to 88.9% from 85.5% in 2024, reflecting Medicare funding reductions, Inflation Reduction Act changes, and faster medical-cost trends. (unitedhealthgroup.com) Peers reported the same pressure in different forms. Elevance Health said its 2025 benefit expense ratio rose to 90.0% from the prior year because of elevated medical-cost trends, while Humana said its 2025 insurance segment benefit ratio was 90.4% and guided to at least $9.00 in adjusted earnings per share for 2026, down from $17.14 in 2025. (elevancehealth.com, humana.com) Medicare Advantage sits near the center of the reset because private insurers bid a year ahead and then absorb the risk if care comes in hotter than expected. The Centers for Medicare & Medicaid Services said its final 2026 rate notice would raise Medicare Advantage payments by 5.06%, or more than $25 billion, after insurers had argued earlier proposals were too low. (cms.gov) Analysts have not turned uniformly bearish. Investing.com reported on April 14, 2026, that RBC Capital kept its Outperform rating on UnitedHealth and a $361 price target, even as the firm acknowledged a tougher earnings setup. (investing.com) Company guidance shows why the market is separating balance-sheet strength from sector risk. UnitedHealth projected 2026 adjusted earnings above $17.75 a share on January 27, 2026, while Elevance projected at least $25.50 and said it was recalibrating margin targets rather than abandoning them. (unitedhealthgroup.com, elevancehealth.com) The regional split also reflects different business mixes. Many Asian and European insurers have less direct exposure to United States Medicare Advantage utilization and more earnings from life insurance, property and casualty coverage, or domestic health systems with different pricing rules. (insuranceasia.com, globaldata.com) What changed in early 2026 was not the existence of medical inflation, but the market’s willingness to pay old multiples for companies still proving they can price it correctly. For now, analysts are still backing some of the biggest names, while investors are charging more for the risk. (investing.com, insuranceasia.com)
